In large clinical trials, a full dose anticoagulation (blood thinner) treatment given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support, such as the need for mechanical ventilation.
A trend in possible reduction of mortality was also observed and is being further studied.
Full-dose Blood Thinners Improved Hospitalized COVID-19 Patient Outcomes
FDA Approves the First Long-acting Regimen for HIV Treatment
The U.S. Food and Drug Administration (FDA) announced the approval of Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults.
This is the first FDA-approved injectable, complete regimen for HIV-infected adults administered once a month.
Total Pediatric ED Visits Decreased in 2020 Versus 2018, 2019
Total trauma number decreased by 34 percent, but proportion of trauma increased significantly
Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load
No significant reduction seen in viral load at day 11 with bamlanivimab monotherapy in mild-to-moderate COVID-19
Cancer Screening, Diagnoses Down During Early Pandemic
Higher positivity rate during the early pandemic might reflect prioritizing of higher-risk patients
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 19 to 22, 2021. This …
Adults Delaying Even Emergency Care During COVID-19
More than half report being hesitant going to doctor or hospital when COVID-19 cases are high
Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19
Preliminary results of the study conducted by drug maker Eli Lilly have not been peer-reviewed or published